We showed that loss of Kindlin-2 in BC cell lines of both human and mouse origin resulted in a significant increase in expression levels of SerpinB2 and p21, the two well-established p53-responsive genes, both in vitro and in tumor xenografts. The gene discussed is FERMT2; the disease is breast cancer.